These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
497 related items for PubMed ID: 6934088
1. Absorption of theophylline from conventional and sustained-release tablets. Mellstrand T, Svedmyr N, Fagerström PO. Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088 [Abstract] [Full Text] [Related]
2. Absorption of theophylline from conventional and sustained-release tablets. Fagerström PO, Mellstrand T, Svedmyr N. Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455 [Abstract] [Full Text] [Related]
3. Absorption of sustained-release theophylline tablets. Fagerström PO, Heintz L. Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):359-62. PubMed ID: 6885207 [Abstract] [Full Text] [Related]
4. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses. Schuppan D, Molz KH, Staib AH, Rietbrock N. Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238 [Abstract] [Full Text] [Related]
10. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men. Dockhorn RJ, Cefali EA, Straughn AB. Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214 [Abstract] [Full Text] [Related]
11. Variations in absorption of theophylline from two sustained-release products. Ferrari M, Olivieri M, Barozzi E, Ramponi C. Clin Ther; 1986 Mar; 8(6):646-54. PubMed ID: 3791362 [Abstract] [Full Text] [Related]
12. Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet. Lagas M, Jonkman JH. Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):424-6. PubMed ID: 4044074 [Abstract] [Full Text] [Related]
13. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur. Takagi K, Hasegawa T, Ogura Y, Yamaki K, Suzuki R, Satake T, Imaeda N, Mizukami Y. Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057 [Abstract] [Full Text] [Related]
15. The relation of product formulation to absorption of oral theophylline. Weinberger M, Hendeles L, Bighley L. N Engl J Med; 1978 Oct 19; 299(16):852-7. PubMed ID: 692577 [Abstract] [Full Text] [Related]
16. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets. Jonkman JH, van der Boon WJ, Schoenmaker R, Holtkamp A, Thürkow-Luikens AJ. Int J Clin Pharmacol Ther Toxicol; 1984 Sep 19; 22(9):506-10. PubMed ID: 6500770 [Abstract] [Full Text] [Related]
17. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis. Valet SB, Schwartz RH, Brooks JG. Ann Allergy; 1983 Mar 19; 50(3):161-5. PubMed ID: 6829982 [Abstract] [Full Text] [Related]
18. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I. Ohmori N, Inotsume N, Matsukura M, Higashi A, Iwaoku R, Tobino Y, Nakano M, Matsuda I. Int J Clin Pharmacol Ther Toxicol; 1986 Mar 19; 24(3):148-52. PubMed ID: 3699941 [Abstract] [Full Text] [Related]